• 1. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 2. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Methyl 4-bromo-2-(methylsulfonyl)benzoate (CAS No. 773134-43-3): A Versatile Intermediate in Modern Chemical Biology

Methyl 4-bromo-2-(methylsulfonyl)benzoate, identified by its CAS number 773134-43-3, is a significant compound in the realm of chemical biology and pharmaceutical research. This organic molecule, characterized by its brominated aromatic ring and methylsulfonyl substituent, has garnered considerable attention due to its utility as a key intermediate in the synthesis of various bioactive molecules.

The structural motif of Methyl 4-bromo-2-(methylsulfonyl)benzoate consists of a benzoate backbone, which is a well-documented scaffold in medicinal chemistry. The presence of a bromine atom at the 4-position and a methylsulfonyl group at the 2-position imparts unique reactivity and electronic properties to the molecule. These features make it an invaluable building block for designing novel compounds with potential therapeutic applications.

In recent years, the demand for specialized intermediates like Methyl 4-bromo-2-(methylsulfonyl)benzoate has surged, driven by advancements in drug discovery and development. The compound's ability to undergo various chemical transformations, such as nucleophilic aromatic substitution and Suzuki-Miyaura coupling, makes it particularly useful in constructing complex molecular architectures. These reactions are often employed in the synthesis of small-molecule inhibitors targeting critical biological pathways.

One of the most compelling aspects of Methyl 4-bromo-2-(methylsulfonyl)benzoate is its role in the development of kinase inhibitors. Kinases are enzymes that play a pivotal role in cell signaling, and their dysregulation is associated with numerous diseases, including cancer. Researchers have leveraged the reactivity of this compound to design inhibitors that selectively target specific kinases. For instance, derivatives of Methyl 4-bromo-2-(methylsulfonyl)benzoate have been explored as potential inhibitors of tyrosine kinases, which are overactive in many cancer types.

The methylsulfonyl group in Methyl 4-bromo-2-(methylsulfonyl)benzoate contributes to the compound's ability to interact with biological targets through both hydrophobic and electrostatic interactions. This feature has been exploited in the design of molecules that exhibit high binding affinity to protein receptors. Additionally, the bromine atom serves as a handle for further functionalization, allowing chemists to introduce additional substituents that can modulate biological activity.

Recent studies have highlighted the utility of Methyl 4-bromo-2-(methylsulfonyl)benzoate in the synthesis of antiviral agents. The growing threat of viral infections has prompted researchers to explore novel chemical entities that can interfere with viral replication cycles. The structural features of this compound have been found to be conducive for designing molecules that inhibit viral proteases and polymerases. Such inhibitors are crucial for developing new antiviral drugs that can combat emerging viral threats.

The versatility of Methyl 4-bromo-2-(methylsulfonyl)benzoate extends beyond its applications in drug discovery. It has also been utilized in materials science, where its ability to form stable complexes with metal ions makes it useful in the development of coordination polymers and metal-organic frameworks (MOFs). These materials have potential applications in catalysis, gas storage, and separation technologies.

In conclusion, Methyl 4-bromo-2-(methylsulfonyl)benzoate (CAS No. 773134-43-3) is a multifaceted compound with broad applications in chemical biology and pharmaceutical research. Its unique structural features and reactivity make it an indispensable tool for synthetic chemists working on the development of novel bioactive molecules. As research continues to uncover new therapeutic targets and challenges, compounds like this will remain at the forefront of innovation in drug discovery and beyond.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)